Health Sciences

UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.

The Latest

Up and Running: Students Wow the Crowds at Triton Entrepreneur Night

Excitement was palpable at UC San Diego’s inaugural Triton Entrepreneur Night as student entrepreneurs, alumni, staff, and community supporters gathered for demos and presentations from the latest crop of student-driven innovations.

It Takes a Community to Raise a Startup: Winners Stand Out at UC San Diego Entrepreneur Challenge

Students and researchers at all stages of their academic careers went head-to-head recently, competing for $100k in prizes at the 10th annual UC San Diego Entrepreneur Challenge.

CIRM Grants May Fund the Next Great Stem Cell Achievement

All scientific achievement begins with an idea. Yesterday, three researchers at University of California San Diego School of Medicine were awarded funding by the Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) to pursue budding ideas that might eventually impact the field of human stem cell research.

UC San Diego Joins IBM World Community Grid’s Search for Zika Treatment

IBM's World Community Grid and scientists from Brazil, the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, and Rutgers New Jersey Medical School have launched OpenZika, a project to find drug candidates to treat Zika, a fast spreading virus that the World Health Organization has declared a global public health emergency.

UC San Diego to Participate in White House’s National Microbiome Initiative

On May 13, the White House Office of Science and Technology Policy (OSTP) announced a new National Microbiome Initiative, a coordinated effort to better understand microbiomes and to develop tools to protect and restore healthy microbiome function. OSTP is launching the initiative with a combined federal agency investment of more than $121 million. The University of California San Diego is a key participant in this effort, investing $12 million in its own microbiome research efforts.

UC San Diego Sparks New Cancer-Focused Startup, Oncternal, with Exclusive Antibody License

Oncternal Therapeutics, a new cancer-focused biotechnology startup, has signed a wide-ranging licensing agreement with UC San Diego to develop and commercialize antibodies and antibody-related binding agents.